SCHOLAR ROCK HOLDING CORP (SRRK) Fundamental Analysis & Valuation
NASDAQ:SRRK • US80706P1030
Current stock price
46.73 USD
+0.44 (+0.95%)
At close:
46.73 USD
0 (0%)
After Hours:
This SRRK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SRRK Profitability Analysis
1.1 Basic Checks
- In the past year SRRK has reported negative net income.
- In the past year SRRK has reported a negative cash flow from operations.
- In the past 5 years SRRK always reported negative net income.
- SRRK had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -93.49%, SRRK is not doing good in the industry: 73.98% of the companies in the same industry are doing better.
- SRRK has a Return On Equity of -153.95%. This is in the lower half of the industry: SRRK underperforms 65.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -93.49% | ||
| ROE | -153.95% | ||
| ROIC | N/A |
ROA(3y)-47.57%
ROA(5y)-41.66%
ROE(3y)-64.04%
ROE(5y)-60.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- SRRK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. SRRK Health Analysis
2.1 Basic Checks
- SRRK has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for SRRK has been increased compared to 5 years ago.
- The debt/assets ratio for SRRK is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 13.43 indicates that SRRK is not in any danger for bankruptcy at the moment.
- SRRK's Altman-Z score of 13.43 is amongst the best of the industry. SRRK outperforms 84.85% of its industry peers.
- SRRK has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
- With a Debt to Equity ratio value of 0.41, SRRK is not doing good in the industry: 71.84% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 13.43 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 6.95 indicates that SRRK has no problem at all paying its short term obligations.
- The Current ratio of SRRK (6.95) is better than 66.80% of its industry peers.
- SRRK has a Quick Ratio of 6.95. This indicates that SRRK is financially healthy and has no problem in meeting its short term obligations.
- With a decent Quick ratio value of 6.95, SRRK is doing good in the industry, outperforming 66.99% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.95 | ||
| Quick Ratio | 6.95 |
3. SRRK Growth Analysis
3.1 Past
- SRRK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -39.43%.
EPS 1Y (TTM)-39.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, SRRK will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.32% on average per year.
- Based on estimates for the next years, SRRK will show a very strong growth in Revenue. The Revenue will grow by 437.09% on average per year.
EPS Next Y3.9%
EPS Next 2Y12.5%
EPS Next 3Y18.08%
EPS Next 5Y19.32%
Revenue Next Year12665.8%
Revenue Next 2Y2745.46%
Revenue Next 3Y1140.18%
Revenue Next 5Y437.09%
3.3 Evolution
4. SRRK Valuation Analysis
4.1 Price/Earnings Ratio
- SRRK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year SRRK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as SRRK's earnings are expected to grow with 18.08% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.5%
EPS Next 3Y18.08%
5. SRRK Dividend Analysis
5.1 Amount
- SRRK does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
SRRK Fundamentals: All Metrics, Ratios and Statistics
46.73
+0.44 (+0.95%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-03 2026-03-03/bmo
Earnings (Next)05-07 2026-05-07
Inst Owners110.69%
Inst Owner Change-0.34%
Ins Owners2.98%
Ins Owner Change0.54%
Market Cap5.37B
Revenue(TTM)N/A
Net Income(TTM)-377.94M
Analysts87.27
Price Target59.16 (26.6%)
Short Float %13.4%
Short Ratio9.73
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.05%
Min EPS beat(2)-5.19%
Max EPS beat(2)3.09%
EPS beat(4)2
Avg EPS beat(4)-11.51%
Min EPS beat(4)-44.57%
Max EPS beat(4)3.09%
EPS beat(8)4
Avg EPS beat(8)-7.91%
EPS beat(12)7
Avg EPS beat(12)-2.47%
EPS beat(16)10
Avg EPS beat(16)4.95%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.18%
PT rev (3m)17.51%
EPS NQ rev (1m)0.81%
EPS NQ rev (3m)7.95%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 21.87 | ||
| P/tB | 21.87 | ||
| EV/EBITDA | N/A |
EPS(TTM)-3.43
EYN/A
EPS(NY)-3.3
Fwd EYN/A
FCF(TTM)-1.75
FCFYN/A
OCF(TTM)-1.75
OCFYN/A
SpS0
BVpS2.14
TBVpS2.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -93.49% | ||
| ROE | -153.95% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-47.57%
ROA(5y)-41.66%
ROE(3y)-64.04%
ROE(5y)-60.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.41 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 5.06% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 6.95 | ||
| Quick Ratio | 6.95 | ||
| Altman-Z | 13.43 |
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)14.34%
Cap/Depr(5y)103.43%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.26%
EPS Next Y3.9%
EPS Next 2Y12.5%
EPS Next 3Y18.08%
EPS Next 5Y19.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year12665.8%
Revenue Next 2Y2745.46%
Revenue Next 3Y1140.18%
Revenue Next 5Y437.09%
EBIT growth 1Y-52.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-60.77%
EBIT Next 3Y-3.17%
EBIT Next 5Y11.81%
FCF growth 1Y-38.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.37%
OCF growth 3YN/A
OCF growth 5YN/A
SCHOLAR ROCK HOLDING CORP / SRRK Fundamental Analysis FAQ
What is the fundamental rating for SRRK stock?
ChartMill assigns a fundamental rating of 2 / 10 to SRRK.
What is the valuation status for SRRK stock?
ChartMill assigns a valuation rating of 0 / 10 to SCHOLAR ROCK HOLDING CORP (SRRK). This can be considered as Overvalued.
Can you provide the profitability details for SCHOLAR ROCK HOLDING CORP?
SCHOLAR ROCK HOLDING CORP (SRRK) has a profitability rating of 0 / 10.
How financially healthy is SCHOLAR ROCK HOLDING CORP?
The financial health rating of SCHOLAR ROCK HOLDING CORP (SRRK) is 5 / 10.